Pages

Saturday, August 20, 2022

WHY DID THE MODERNA CEO RECENTLY ADMIT: "It's sad to say, but I'm in the process of throwing 30 MILLION doses into the GARBAGE because NOBODY wants them..." ???

        

Could THIS have something to do with it? ...

Young Men's Myocarditis Risk 5 Times Higher With Moderna vs Pfizer Vax

MEDPAGETODAY

Cases of myocarditis or pericarditis were highest in men ages 18-24, reaching 299.5 cases per million second doses of Moderna's vaccine (95% CI 171.2-486.4), as compared to 59.2 cases per million second doses of Pfizer's vaccine (95% CI 19.2-138.1), reported Sarah Buchan, PhD, of Public Health Ontario in Toronto, and colleagues in JAMA Network Open. [READ FULL ARTICLE]



Just curious... how much are you charging people for a single vaccine dose -- AND -- exactly how much does it cost you to manufacture each one at the factory?

The costs of coronavirus vaccines and their pricing

Donald W Light, Joel Lexchin - First Published November 3, 2021 - Journal of the Royal Society of Medicine - https://doi.org/10.1177/01410768211053006

According to a BMJ report in January 2021, Moderna and Pfizer were charging more affluent nations and the EU for their mRNA vaccines with prices ranging from $14.70 to $23.50 a dose. Do their costs of developing and manufacturing vaccines, net of public subsidies, justify these prices, or are the companies just ‘making a killing’ as a recent BMJ commentary put it?

As with prices, and contrary to the ethics of vaccines as a public health good, companies have kept manufacturing costs for all vaccines secret, and only a few independent studies have researched them in detail. Our analysis is based on this literature as well as an in-depth investigation done with Doctors Without Borders...

Based on two large, fully equipped, state-of-the-art facilities in the USA and EU, the high estimate of the most recent study, when spread out over 100 million doses a year and annualised over the life of the plant and equipment, comes to about US$ 0.20 a dose...

A reasonable estimate for comparable staff in the Developing Country Vaccine Manufacturers Network would be about half or US$ 0.09 a dose. [READ FULL ARTICLE]


MORE:








PREVIOUSLY ON AFROPERSPECTIVES:





No comments: